GLIMCHER LAURIE H has a total of 17 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2004. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CENTRE LEON BERARD, PSYCHIATRIC GENOMICS INC and ACEA BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 5 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Agriculture | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Analysing materials | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Peptides | |
#6 | Animal care | |
#7 | Heterocyclic compounds | |
#8 | Acyclic or carbocyclic compounds | |
#9 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Glimcher Laurie H | 16 |
#2 | Wein Marc | 2 |
#3 | Szabo Susanne J | 2 |
#4 | Lee Ann-Hwee | 2 |
#5 | Jones Dallas C | 2 |
#6 | Vacca Joseph P | 1 |
#7 | Martinon Fabio | 1 |
#8 | Hwang Eun S | 1 |
#9 | Cubillos-Ruiz Juan Rodrigo | 1 |
#10 | Bettigole Sarah | 1 |
Publication | Filing date | Title |
---|---|---|
WO2018161033A1 | Small molecule ire1-alpha inhibitors | |
WO2018102655A1 | Ascites based methods | |
US2012141539A1 | Methods for modulating toll-like receptor mediated activation of cells of the innate system by modulating xbp-1 activity | |
US2009232738A1 | Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity | |
US2009298091A1 | Modulation of T cell recruitment |